Donald M. Engelman, PhD
CHAIRMAN OF THE SCIENTIFIC ADVISORY BOARD
Donald Engelman is the Eugene Higgins Professor of Molecular Biophysics and Biochemistry at Yale. Don is a Member of the Yale Cancer Center, and an elected member of the National Academy of Sciences, the American Academy of Arts and Sciences, and other societies. He is an inventor of the pHLIP® technology and an expert in membrane biophysics, biochemistry, cell and molecular biology, and cancer biology. Don has many years of experience as a consultant and served as a Director of the Stryker Corporation from 1989 through 2010. Don has led review and steering groups at the NIH, NSF, American Cancer Society, Brookhaven National Laboratory, Los Alamos National Laboratory, and the Institut Laue Langevin, among others. He has also served on several nonprofit boards, including the Wenner-Gren Foundation and the Board of Trustees of Reed College.
Oleg A. Andreev, PhD
Member of the Scientific Advisory Board
Oleg Andreev is Professor of Physics at the University of Rhode Island (URI) and Adjunct Professor at the Rhode Island Hospital, Radiation Oncology, Warren Alpert Medical School of Brown University. Prior to joining faculty at URI, Oleg has had industry experience as a Lead Scientist in a Harvard-based Startup. At URI, Oleg has led the Physics Department as its Chairman from 2013 to 2019. He served as a member of the Institutional Intellectual Property Committee for several years. Oleg is an inventor of the pHLIP® technology and an expert in biochemistry, optics, imaging, cancer nanotechnology, and animal studies. He has about two decades of experience in the development of pHLIP® imaging and therapeutic products, and is a co-author of about 60 pHLIP® patents and patent applications. Oleg has received URI Research and IP excellence Awards, Outstanding Inventor Awards, and the Maitland P. Simmons Memorial Research Award.
Peter M. Glazer, PhD, MD
Member of the Scientific Advisory Board
Peter Glazer is the Hunter Professor of Therapeutic Radiology, Genetics and Chair of the Department of Therapeutic Radiology at Yale University. Peter has had longstanding research interests in tumor hypoxia, DNA repair, cancer therapy and gene editing. Peter has conducted NIH funded research programs in these areas for over 25 years, recently receiving an Outstanding Investigator Award from the NCI. Peter has served as the program leader of the Yale Cancer Center’s Radiobiology and Radiotherapy research program for more than 20 years, and Peter has founded or served on the SAB of several biotech companies, including Codon, Helix, Cybrexa and Trucode. Peter has received research awards from the American Society for Photobiology, the Radiation Research Society, the Leukemia and Lymphoma Society, and the John Yuhas Award from the University of Pennsylvania.
Mark A. Lemmon, PhD, FRS
Member of the Scientific Advisory Board
Mark Lemmon is the David A. Sackler Professor of Pharmacology at Yale, Co-Director of the Cancer Biology Institute, and Associate Director for Basic Science of the Yale Cancer Center. Mark’s laboratory focuses on mechanistic, structural, and biochemical aspects of signaling by growth factor receptor tyrosine kinases such as the EGF receptor, and on mechanism-guided targeted therapy. Educated in Oxford (BA), Yale (PhD) and NYU (postdoc), Mark became an Assistant Professor of Biochemistry and Biophysics at the University of Pennsylvania in 1996. After 20 years at Penn, latterly as Chair of Biochemistry and Biophysics, Mark returned to Yale. Mark serves on advisory boards of several cancer research programs, and on Editorial Boards of Cell, Molecular Cell, Science Signaling, Biochemical Journal and other journals. Mark was ASBMB Secretary from 2007 to 2013, received Penn’s Stanley Cohen Research Award and the Protein Society’s Dorothy Crowfoot Hodgkin Award. Mark is an elected Fellow of the Royal Society.
Jason S. Lewis, PhD
Member of the Scientific Advisory Board
Jason Lewis is the Emily Tow Jackson Chair in Oncology at Memorial Sloan Kettering Cancer Center (MSKCC) and currently serves as Vice Chair for Research and as the Chief of the Radiochemistry and Imaging Sciences Service in MSKCC’s Department of Radiology. Jason is the Director of MSKCC’s Radiochemistry and Molecular Imaging Probe Core Facility and the MSKCC Center for Molecular Imaging and Nanotechnology. Jason is a Member in MSKCC, Laboratory Head in the Sloan-Kettering Institute’s Molecular Pharmacology and Chemistry Program, and a Professor at the Gerstner Sloan-Kettering Graduate School of Biomedical Sciences and at Weill-Cornell Medical College. Jason served as the President of the World Molecular Imaging Society (2014-2015) and was named a Fellow of the World Molecular Imaging Society and was the 2017 SNMMI Michael J. Welch Award winner. Jason is the Editor-In-Chief of “Molecular Imaging and Biology”.
Ruslan M. Medzhitov, PhD
Member of the Scientific Advisory Board
Ruslan Medzhitov is the Sterling Professor of Immunobiology at the Yale University School of Medicine and an Investigator of the Howard Hughes Medical Institute. Ruslan’s research interests include the biology of inflammation, metabolism, immunology and evolutionary medicine. He is an elected member of the National Academy of Sciences and the National Academy of Medicine, the European Molecular Biology Organization, a fellow of the American Academy of Microbiology and a foreign member of the Russian Academy of Sciences. Ruslan’s awards include the William B. Coley Award, Cancer Research Institute, 2003; the Emil von Behring Award, 2004; the AAI BD Biosciences Investigator Award, 2006; the Blavatnik Award for Young Scientists, 2007; the Howard Taylor Ricketts Award, The University of Chicago, 2008; the Lewis S. Rosenstiel Award, Brandeis University, 2010; the Shaw Prize in Life Science and Medicine, 2011; the Vilcek Prize, New York, 2013; the Lurie Prize, Chicago, 2013; the Else Kröner Fresenius Stiftung Prize, Germany, 2013 and the Charles W. Bohmfalk Teaching Prize, 2015.
David Wolfsohn, MD, AGAF, FACG
Member of the Scientific Advisory Board
David Wolfsohn is a Clinical Assistant Professor at the Yale School of Medicine and a managing partner at Connecticut Gastroenterology Consultants. David has 30 years of experience with expertise in endoscopic and surgical imaging, vast involvement at the local and national levels in quality assurance, pharmacology, and therapeutics. He is the former governor of the American College of Gastroenterology, National Patient Care Committee member, Anthem’s Pharmaceutical and Therapeutics Committee, Yale GI Leadership Committee, and served as a Yale ambulatory endoscopy director for more than a decade. David is a Board certified gastroenterologist and prior emergency medicine physician. He is a Fellow of the American Gastroenterology Association, American College of Gastroenterology, and Jonathan Edwards College of Yale University. David is the recipient of the Vincent DeLuca Yale Teaching Award.
